Data as of Mar 14
| -1.40 / -4.35%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 37.50, with a high estimate of 53.00 and a low estimate of 30.00. The median estimate represents a +21.67% increase from the last price of 30.82.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.